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Plasma and cerebrospinal fluid arginine vasopressin
in patients with and without fever
P M Sharples, J R Seckl, D Human, S L Lightman, D B Dunger
Abstract
Hyponatraemia has been described in asso-
ciation with a number of acute infectious
diseases, mainly bacterial and tuberculous
meningitis and pneumonia, and has been attri-
buted to inappropriate secretion of arginine
vasopressin (AVP). The mechanism of in-
appropriate AVP production is uncertain, but
there is experimental evidence to suggest that
fever may stimulate secretion of AVP into
plasma and cerebrospinal fluid. In this study,
AVP concentrations in plasma and cerebro-
spinal fluid from 37 febrile children with
infections have been compared with those
from 27 afebrile control subjects. Ten of the
febrile children had meningitis (eight bacterial,
two viral) and the remainder a variety of other
infectious diseases. Seventy four per cent of
febrile infected children were hyponatraemic
(serum sodium <135 mmol/l) compared with
only 8% of the afebrile controls. Plasma AVP
concentrations were significantly higher in the
febrile patients (median 2-92 pmol/l, range
1-0-23*25, n=28) than in controls (median
1-67 pmol/l, range 0O57-6*0, n=14) but there
was no significant difference in cerebrospinal
fluid AVP concentrations. There was no
difference in plasma AVP concentrations
between patients with meningitis and those
with infections not involving the central
nervous system. Careful attention should be
paid to fluid and electrolyte balance in all
children with acute infections.
(Arch Dis Child 1992;67:998-1002)
Department of
Child Health,
The Medical School,
Framlington Place,
Newcastle upon Tyne
NE2 4HH
P M Sharples
Department of Medicine,
Western General
Hospital,
Edinburgh
J R Seckl
Department of
Paediatrics,
John Radcliffe Hospital,
Oxford
D Human
D B Dunger
Department of Medicine,
Charing Cross and
Westminster Medical
School,
London
S L Lightman
Correspondence to:
Dr Sharples.
Accepted 10 April 1992
Hyponatraemia and water retention have been
reported in children with bacterial and tubercu-
lous meningitis, 1-4 viral encephalitis5 and
pneumonia.4 6 7 These findings have been attri-
buted to inappropriate secretion of arginine
vasopressin (AVP) and in a few studies plasma
or cerebrospinal fluid AVP concentrations have
been measured and shown to be increased. ' 6 8
The mechanism of the inappropriate AVP
production in these situations remains un-
certain,8 although it has been suggested that
increased AVP concentrations in pneumonia
may be the result of intrathoracic pathology
interfering with the normal modulation of AVP
release via stretch and baroreceptors in the left
atrium and carotid sinus.9
Experimental studies have indicated that in a
variety of animal species, AVP production,
hyponatraemia, and hypo-osmolality can be
produced by inducing pyrexia. 1'2 These
observations have led to suggestions that AVP
may have a role as an endogenous antipyretic. 13 14
This hypothesis might explain the findings of
Gonzalez et al who noted an association between
hyponatraemia and a variety ofacute infections.'5
However, there is little published information
concerning plasma or cerebrospinal fluid AVP
concentrations in acute infections other than
those of the central nervous or respiratory
systems.
The aim of this study was to determine the
concentrations ofAVP in samples of plasma and
cerebrospinal fluid obtainedfrom febrile children
with a variety of infectious diseases and compare
these with the concentrations found in a group
of afebrile control children.
Patients and methods
The study population comprised 37 febrile
children with a variety of acute infectious
illnesses (table 1). Ten children had meningitis
(eight bacterial, two viral). The median age of
the study population was 2 5 years, range
2 weeks-14 years; 20 (54%) were boys. All the
children were hospital inpatients. Samples were
obtained shortly after admission at a time when
venepuncture or lumbar puncture was being
performed for a clinical indication. The body
temperature was recorded immediately before
Table I Details of the febrile children
Patient Age Sex Diagnosis
No (years)
I 10 F Pneumonia
2 2-5 F Upper respiratory tract infection
3 1-5 M Salmonella enteritis
4 11 M Pyrexia of unknown origin
5 1-33 M Viral illness
6 12 M Urinary tract infection
7 14 F Urinary tract infection
8 5 M Viral illness
9 0-75 M Viral illness
10 1-66 F Viral illness
11 1-33 F Tonsillitis
12 1-0 F Celiulitis
13 3 F Viral illness
14 9 M Otitis media
15 1 F Otitis media
16 1 M Viral illness
17 0-16 M Pneumonia
18 0-16 M Viral illness
19 11 M Upper respiratory tract infection
20 10 M Osteomyelitis
21 0 50 F Otitis media
22 5 F Viral illness
23 1-5 F Upper respiratory tract infection
24 0-04 F Viral illness
25 1-75 M Cellulitis
26 5 M Viral illness
27 13 M Viral illness
28 2-5 F Bacterial meningitis
29 12 F Bacterial meningitis
30 7 M Bacterial meningitis
31 9 F Bacterial meningitis
32 0-25 M Bacterial meningitis
33 8 F Bacterial meningitis
34 1-42 F Bacterial meningitis
35 1 M Bacterial meningitis
36 5 M Viral meningitis
37 7 M Viral meningitis
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sampling. Plasma samples for AVP determina-
tion were obtained from 28 febrile children and
cerebrospinal fluid samples from 19. Paired
plasma and cerebrospinal fluid samples were
obtained in nine of the children. No child was
hypotensive or clinically dehydrated at the time
of sampling.
The afebrile control population consisted of
two groups, totalling 27 children: 15 children
who were seen as outpatients for a variety of
conditions (table 2), and from whom plasma
samples were obtained, and 12 inpatients who
underwent lumbar puncture for various clinical
indications (table 3) and who provided cerebro-
spinal fluid samples. The median age of the con-
trol population was 7 0 years, range 1 month-15
years; 13 (48%) were boys. There was no signifi-
cant difference between the age structure of the
study and control groups (Mann-Whitney U
test, p=0 13).
Blood (0 5-1 0 ml) was taken onto ice,
centrifuged immediately, and the plasma
separated and stored at -20°C until assay.
Cerebrospinal fluid (0 5 ml) was also taken onto
ice and stored at -20°C. Immediately before
AVP assay, the plasma sample was extracted
through octadecasilyl silica cartridges (Sep-pak
C1 8, Waters Associates). TheAVP concentration
in plasma and cerebrospinal fluid was measured
by radioimmunoassay, as described previously. 16
The intra-assay coefficient of variation was 5%
and the interassay coefficient of variation 15%.
The limit of detection of the assay was 0'30
pmol/l. In the data analysis, a non-detectable
concentration of AVP was assigned a value of
0-00 pmol/1.8
The study was approved by the local ethical
committee.
Table 2 Details of
plasma samples
the afebrile children who provided
Patient Age Sex Diagnosis
No (years)
1 4 M Asthma
2 0-25 F Skeletal dysplasia
3 0-83 M Constipation
4 0104 M Feeding difficulties
5 10 F Bell's palsy
6 5 F Asthma
7 2 M Failure to thrive
8 1 M ?Breath holding attacks ?Fits
9 8 F Acute leukaemia
10 14 M Constitutional short stature
11 12 F Friedreich's ataxia
12 13 M Constitutional short stature
13 0 75 F Failure to thrive
14 15 M Constitutional short stature
15 12 F Diabetes meilitus
Table 3 Details of the afebrile children who provided
cerebrospinal fluid samples
Patient Age Sex Diagnosis
No (years)
1 0-02 F ?Seizure
2 0-58 M Seizures
3 14 M Headache ?meningitis
4 13 F Staging for acute leukaemia
5 10 F Staging for acute leukaemia
6 11 M Neck stiffness ?meningitis
7 11 M Guillain-Barre syndrome
8 5 M Epilepsy
9 9 F Headache ?meningitis
10 4 F Staging for acute leukaemia
11 7 F Staging for non-Hodgkin's lymphoma
12 15 F Staging for acute leukaemia
Results
Figure 1 shows the plasma AVP results obtained
in febrile and afebrile patients. The plasma
AVP concentrations obtained from the febrile
children (median 2-92 pmol/l, range 1-00-23'25)
were significantly higher than those obtained
from the afebrile controls (median 1-67 pmol/l,
0'57-6'0) (Mann-Whitney U test, p=0.003).
The difference between febrile and afebrile
subjects persisted if children with meningitis
were excluded from the analysis (median plasma
AVP concentration among febrile, non-
meningitic patients 2-49 pmol/l, range
1'0-23'25) (Mann-Whitney U test, p=01036).
Plasma AVP concentrations in the meningitic
children (median 4 14 pmol/l, range 1 16-15'25,
n=6) were not in fact significantly different
from those observed in the other febrile chil-
dren (Mann-Whitney U test, p=0 10). There
was no difference in plasma AVP concentrations
according to sex, either when all the patients
were considered together (Mann-Whitney
U test, p=0 10) or in the febrile and afebrile
subgroups. There was also no correlation
between plasma AVP concentration and age (r=
-0'06, p=0 70).
There was no significant difference between
the cerebrospinal fluid AVP concentrations
obtained from the febrile study children (median
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Figure I Plasma AVP concentrations (pmolll) infebrile
children with acute infections compared with febrile control
children. Among thefebrile children, the triangular symbols
represent those with bacterial or viral meningitis and the
circular symbols, those with other acute infections.
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0-7 pmolIl, range 0-5 57) and those obtained
from the afebrile control children (median 1-06
pmol/l, range 0-2-9) (Mann-Whitney U test,
p=038) (fig 2). There was also no significant
difference between the AVP cerebrospinal fluid
concentrations obtained from children with
meningitis (median 0-56 pmol/l, range 0-5-57,
n= 8) and those obtained from other febrile
children (median 0 90 pmol/l, range 0-1 98,
n=10) (Mann-Whitney U test, p>005). As
with the plasma results, no correlation was
found between cerebrospinal fluid AVP concen-
tration and age (r=0-22, p=0 10) and there was
also no significant difference in the results
obtained from boys and girls (Mann-Whitney
U test, p=0 24).
Figure 3 illustrates the relationship between
body temperature and plasma AVP concentra-
tions in the febrile children. There was no
correlation between body temperature and
plasma AVP concentration (r=0-09), p> 0 05).
There was also no correlation between body
temperature and cerebrospinal fluid AVP con-
centration (fig 4) (r=0-23, p> 005). Among
the nine children from whom paired plasma and
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Figure 4 Relationship between body temperati
cerebrospinalfluid AVP concentration (pmolll)
febrile children from whom cerebrospinalfluid so
obtained. The triangular symbols represent child
bacterial or viral meningitis and the circular symr
represent children with other acute infections. T)
area indicates the lower limit of detection oj
cerebrospinal fluid samples were obtained, there
was no significant correlation between plasma
and cerebrospinal fluid AVP concentrations (r=
0-32, p=040).
Serum sodium concentrations, obtained
concomitantly, were available for 23/37 (62%)
febrile study patients and 12/27 (44%) afebrile
control children. The serum sodium concentra-
tions observed in febrile children (median 132
mmol/l, range 129-140) were significantly lower
than those in the 12 afebrile study children
(median 138 mmol/l, range 133-143) (Mann-
Whitney U test, p=0002). There were 17/23
(74%) febrile children who were hyponatraemic
(serum sodium concentration less than 135
mmol/1),4 whereas only one afebrile control
child was hyponatraemic. Six (35%) of the
hyponatraemic febrile children had meningitis
but the remaining 11 had other acute infections.
There was no significant difference between the
serum sodium results obtained from the children
with meningitis (median 132 mmol/l, range
131-139, n=7) and those obtained from the
other febrile children (median 133 mmol/l,
range 129-140, n= 16) (Mann-Whitney U test,
p=033). There was no correlation between
serum sodium concentration and plasma AVP
concentration in the febrile children (r=0-04,
p> 0 50) nor between serum sodium and cere-
brospinal fluid AVP concentration (r=0-46,
p=0- 18).
Discussion
The results of this study demonstrate that
increased plasma concentrations of AVP occur
not only in children with bacterial meninigitis,
viral encephalitis and pneumonia, as previously
reported, but also in association with a wide
- i range of other acute infections. The occurrence
40 41 of detectable plasma concentrations of AVP in
children with low serum sodium results (<135
ture and mmol/l) confirms the inappropriate nature of(ebrile the AVP secretion. Hyponatraemia has been
aldor vtral previously described in acutely febrile children, '5ildren with and there have been a number of isolated case
reports reporting inappropriate AVP secretion
in tetanus,'7 viral meningitis,'8 and Rocky
Mountain spotted fever.'9 However, no previous
study has demonstrated increased AVP produc-
tion in such a variety of acute infections.
None of the children in this study were on
treatment recognised to be associated with
increased AVP production, such as vincristine,
chlorpropramide, tricyclic antidepressants, or
phenothiazines.9 IncreasedAVP production may
occur in response to pain or anxiety,9 202'1 and
A increased concentrations in unanaesthetised
children might in part reflect the stress associated
with venepuncture or lumbar puncture in this
age group. However, there seems no reason to
suppose that this effect would be confined to the
40-0 40-5 study children, particularly as the age struc-
ture of the study and control groups was
lure and similar.
for the 19 In this study, there was a significant difference
,amples were between plasma AVP concentrations from febrile
lren with and afebrile patients, but no significant differ-
ebshaded ence in the cerebrospinal fluid AVP concentra-
f the assay. tions between study and control groups. It is
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possible that this may reflect the difficulty of
establishing 'control' cerebrospinal fluid values
in a paediatric population. There were 5/12
(42%) afebrile control children who underwent
lumbar puncture because of an actual or suspec-
ted abnormality of the central nervous system
(table 3) and increased cerebrospinal fluid AVP
concentrations have been described in association
with a variety of non-infectious central nervous
system pathologies. 16 22-25 Another methodo-
logical consideration is the fact that it was not
possible to standardise the time of day at which
the samples were obtained; discrepancies in the
sampling times might therefore have obscured
differences between groups in the cerebrospinal
26 nfluid AVP concentrations. However, no
diurnal rhythm of AVP cerebrospinal fluid
concentration has been demonstrated in
humans.27 Moreover, it is recognised that under
physiological conditions, AVP concentrations in
cerebrospinal fluid and blood are differentially
regulated26 and that various stimuli which
increase plasma AVP concentrations may
produce little alteration in cerebrospinal fluid
levels.28 Even when stimulatory effects are
found, AVP release into cerebrospinal fluid has
a greater threshold than release into blood.26 In
the nine cases in this study, in whom paired
blood and cerebrospinal fluid samples were
available, there was no correlation between
plasma and cerebrospinal fluid AVP concentra-
tions. Indeed, it has been suggested that the
increased AVP concentrations in cerebrospinal
fluid described in meningitic children are the
result of leakage from the circulation across a
damaged blood-brain barrier, rather than the
result of increased intracerebral production,8
and this hypothesis would be in keeping with
our observations.
The results of this study do not give any
indication of the pathogenetic mechanism
responsible for the increased plasma concentra-
tions of AVP. The lack of correlation between
body temperature and plasma and cerebrospinal
fluid AVP concentrations is in contrast to the
results of some experimental studies, in which a
relationship between pyrexia and AVP produc-
tion has been demonstrated,'2 14 but in agree-
ment with the results of others, in which a
direct correlation was not found.'0 12 It may be
that, in some species, fever has an 'all or
nothing' effect on AVP production or that a
single temperature measurement does not
reflect accurately the degree of stimulus to AVP
secretion. Alternatively, the mechanism of the
increased AVP production in children with
acute infections may be unrelated to the occur-
rence of fever; certainly, there is experimental
evidence to suggest that the role of AVP as an
antipyretic may vary between species.
Increased plasma concentrations of AVP have
been described in burned children3' and in
postoperative paediatric surgical patients,32 and
it has been suggested that the increased concen-
trations probably represent part of the body's
stress response.9 32 Increased AVP production
in acute infections may occur for the same
reason.3
The finding that inappropriate AVP produc-
tion and hyponatraemia is not an uncommon
phenomenon in febrile children with a variety of
acute infections indicates that the serum sodium
concentration should always be determined
before administering intravenous fluid in such
patients. The significance of the inappropriate
AVP production, in terms of implications for
outcome, is uncertain and was not explored in
this study. Among children with bacterial
meningitis, both the degree of hyponatraemia
on admission and its duration seem to correlate
with long term outcome34 and this has been
attributed to the effect of AVP on brain water
permeability and cerebral oedema.5 Although
this may seem at first to have little relevance to
children with infections not involving the
central nervous system, it has been suggested
that AVP has a role in the pathogenesis of
febrile convulsions through its effect on brain
water permeability.36 In this study, eight chil-
dren (median age 1 6 years, range 1 0-5) under-
went lumbar puncture after a presumed febrile
convulsion; there was no significant difference
in the plasma or cerebrospinal fluid AVP con-
centrations obtained from these children and
those obtained from febrile children in the age
group at risk from febrile convulsions (6
months-6 years37) who did not have convulsions
(Mann-Whitney U test: p=0 0 for plasma;
p=008 for cerebrospinal fluid). However, in
view of the small numbers, further studies
would be necessary to explore this issue and to
investigate the relationship between AVP pro-
duction and hyponatraemia and eventual out-
come in febrile infected children.
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Maternal chickenpox
Maternal chickenpox in early pregnancy has been associated with
abnormalities in the fetus including microphthalmia, cataracts,
Homer's syndrome, microcephaly, and growth defects of limbs,
fingers, and muscles. Congenital varicella syndrome was found in
three of 61 patients (5%) in three previously reported studies.
Now another 40 mothers with first trimester chickenpox have
been reported from Connecticut (James Balducci and colleagues,
Obstetrics and Gynecology 1992;79:5-6). One mother elected for
termination of pregnancy and three had spontaneous abortions.
There is no comment about abnormality in these fetuses. One
fetus was shown by ultrasound examination to have a large
omphalocele and the pregnancy was terminated. None of the
pregnancies was complicated by congenital varicella syndrome as
previously described.
Maternal chickenpox is not common because most mothers
have had the disease in childhood. These authors quote an
incidence of 0-7 per thousand pregnancies but it is not clear
whether that figure is for chickenpox at any stage in pregnancy or
just the first trimester. In any event congenital varicella syndrome
is rare but it should disappear altogether with chickenpox
immunisation (see Archivist 1991:1212).
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